//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
After one patient's synovial sarcoma returned, a clinical trial led MSK helped shrink his tumors by 85%. That same #Tcell therapy is now approved by the @fda.gov. Learn more ⬇️
11mo
How Afami-Cel Immunotherapy Helped a Young Man With Stage 4 Synovial Sarcoma
www.mskcc.org
Learn how a clinical trial for a new type of immunotherapy called TCR therapy benefited a patient with synovial sarcoma.
Memorial Sloan Kettering Cancer Center